tiprankstipranks
Trending News
More News >
Context Therapeutics (CNTX)
NASDAQ:CNTX
US Market

Context Therapeutics (CNTX) Technical Analysis

Compare
123 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Context Therapeutics’s (CNTX) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Context Therapeutics is a Sell.
Context Therapeutics’s (CNTX) 20-Day exponential moving average is 0.63, while Context Therapeutics’s (CNTX) share price is $0.66, making it a Buy.
Context Therapeutics’s (CNTX) 50-Day exponential moving average is 0.69, while Context Therapeutics’s (CNTX) share price is $0.66, making it a Sell.

Context Therapeutics (CNTX) Pivot Points

Jun 30, 2025, 03:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.59
0.60
0.63
0.64
0.66
0.68
0.70
Fibonacci
0.60
0.62
0.63
0.64
0.65
0.66
0.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Context Therapeutics (CNTX) Moving Averages

Jun 30, 2025, 03:22 AM
Period
Simple
Exponential
MA5
0.62Buy
0.63Buy
MA10
0.60Buy
0.62Buy
MA20
0.61Buy
0.63Buy
MA50
0.72Sell
0.69Sell
MA100
0.75Sell
0.82Sell
MA200
1.19Sell
1.23Sell
Context Therapeutics’s (CNTX) 10-Day exponential moving average is 0.62, while Context Therapeutics’s (CNTX) share price is $0.66, making it a Buy.
Context Therapeutics’s (CNTX) 100-Day exponential moving average is 0.82, while Context Therapeutics’s (CNTX) share price is $0.66, making it a Sell.
Context Therapeutics’s (CNTX) stock price is $0.66 and Context Therapeutics’s (CNTX) 50-day simple moving average is 0.72, creating a Sell signal.
Context Therapeutics’s (CNTX) stock price is $0.66 and Context Therapeutics’s (CNTX) 100-day simple moving average is 0.75, creating a Sell signal.
Context Therapeutics’s (CNTX) stock price is $0.66 and Context Therapeutics’s (CNTX) 200-day simple moving average is 1.19, creating a Sell signal.

Context Therapeutics (CNTX) Technical Indicators

Jun 30, 2025, 03:22 AM
Name
Value
Implied Action
RSI (14)
52.42
Neutral
STOCH (9,6)
95.20
Sell
STOCHRSI (14)
35.65
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
14.66
Buy
Williams %R
-64.03
Buy
CCI (14)
62.15
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
41.78
Neutral
ROC
0.00
Buy
Context Therapeutics’s (CNTX) Relative Strength Index (RSI) is 52.42, creating a Neutral signal.
Context Therapeutics’s (CNTX) Trend Strength Indicator (ADX) is 14.66, creating a Buy signal.
Context Therapeutics’s (CNTX) Commodity Channel Index (CCI) is 62.15, creating a Neutral signal.

FAQ

Is CNTX a Buy, Hold, or Sell?
Based on CNTX’s technical indicators, CNTX is a Hold.
    What is CNTX’s RSI (14)?
    CNTX’s RSI (14) is 52.42, which suggests CNTX is a Neutral.
      What is CNTX’s MACD?
      CNTX’s MACD is -0.02, which suggests CNTX is a Sell.
        What is CNTX’s 5-day moving average?
        CNTX’s 5-day moving average is 0.62, which suggests CNTX is a Buy.
          What is CNTX’s 20-day moving average?
          CNTX 20-day moving average is 0.61, which suggests CNTX is a Buy.
            What is CNTX’s 50-day moving average?
            CNTX’s 50-day moving average is 0.72, which suggests CNTX is a Sell.
              What is CNTX’s 200-day moving average?
              CNTX’s 200-day moving average is 1.19, which suggests CNTX is a Sell.
                What is CNTX’s Williams % R (14)?
                CNTX’s Williams % R (14) is -64.03, which suggests CNTX is a Buy.
                  What is CNTX’s CCI (14)?
                  CNTX’s CCI (14) is 62.15, which suggests CNTX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis